drugset
drugset / Trial / NCT06132919

Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)

NCT06132919 ↗

Phase 2 Completed 33 enrolled MC2 Therapeutics
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women with vulvar lichen schelosus (VLS).

Timeline

Start
2023-10-11
Primary completion
2024-11-08
Completion
2024-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject MC2-25 Unknown — Topical

Indications

vulvar lichen sclerosus